Literature DB >> 11131470

The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research.

R C Kessler1.   

Abstract

OBJECTIVE: Research documenting high rates of comorbidity among patients with generalized anxiety disorder (GAD) has led to the suggestion that GAD might best be conceptualized as a prodrome, residual or severity marker of other disorders. Recent research investigating this suggestion is reviewed in this report.
METHOD: A computer search cross-classified the terms 'Generalized Anxiety' and 'Comorbidity'.
RESULTS: Results arguing that GAD is an independent disorder include the finding that GAD is usually temporally primary in cases of comorbidity with major depression, that primary GAD is a significant predictor of subsequent depression and that the course of GAD is independent of comorbidity. Studies in both patient and community samples show that the impairment associated with pure GAD is equivalent to the impairment associated with pure depression.
CONCLUSION: The results reviewed here support the view that GAD as an independent disorder is a major public health problem.

Entities:  

Mesh:

Year:  2000        PMID: 11131470

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  19 in total

Review 1.  Psychological therapies for generalised anxiety disorder.

Authors:  V Hunot; R Churchill; M Silva de Lima; V Teixeira
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Anxiety with panic disorder linked to chromosome 9q in Iceland.

Authors:  Thorgeir E Thorgeirsson; Högni Oskarsson; Natasa Desnica; Jelena Pop Kostic; Jon G Stefansson; Halldor Kolbeinsson; Eirikur Lindal; Nikolai Gagunashvili; Michael L Frigge; Augustine Kong; Kari Stefansson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2003-04-04       Impact factor: 11.025

Review 3.  Role of kappa-opioid receptors in stress and anxiety-related behavior.

Authors:  Ashlee Van't Veer; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

4.  Treatment response for late-life generalized anxiety disorder: moving beyond symptom-based measures.

Authors:  Ashley S Roseman; Jeffrey A Cully; Mark E Kunik; Diane M Novy; Howard M Rhoades; Nancy L Wilson; Amber L Bush; Melinda A Stanley
Journal:  J Nerv Ment Dis       Date:  2011-10       Impact factor: 2.254

5.  Integrating structural and epidemiological research to inform the classification of psychopathology.

Authors:  Ayelet Meron Ruscio
Journal:  Int J Methods Psychiatr Res       Date:  2009-12       Impact factor: 4.035

6.  Cognitive load and emotional processing in generalized anxiety disorder: electrocortical evidence for increased distractibility.

Authors:  Annmarie MacNamara; Greg Hajcak Proudfit
Journal:  J Abnorm Psychol       Date:  2014-06-16

7.  Current diagnosis and treatment of anxiety disorders.

Authors:  Alexander Bystritsky; Sahib S Khalsa; Michael E Cameron; Jason Schiffman
Journal:  P T       Date:  2013-01

8.  The generalized anxiety spectrum: prevalence, onset, course and outcome.

Authors:  Jules Angst; Alex Gamma; David S Baldwin; Vladeta Ajdacic-Gross; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-24       Impact factor: 5.270

9.  Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up.

Authors:  R C Kessler; M Gruber; J M Hettema; I Hwang; N Sampson; K A Yonkers
Journal:  Psychol Med       Date:  2007-11-30       Impact factor: 7.723

10.  Association between anxious symptoms and sleeping medication use among US older adults.

Authors:  Daniel Harris; Lynn McNicoll; Gary Epstein-Lubow; Kali S Thomas
Journal:  Int J Geriatr Psychiatry       Date:  2017-09-29       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.